A modelling group convened by the World Health Organization and UNAIDS has estimated that if efforts are not made to mitigate and overcome interruptions in health services and supplies during the COVID-19 pandemic, a six-month disruption of antiretroviral therapy could lead to more than 500 000 extra deaths from AIDS-related …
Science 2.0 is here as CSIR resorts to open source drug research for TB Sreelatha Menon / New Delhi March 1, 2009, 0:23 IST A global net-based project for finding a new TB drug sets the pace for research into poor man's diseases that don't attract big money. Call it …
Tuberculosis is growing in many places, and strains resistant to all existing drugs are emerging. To fight back, biologists are applying a host of cutting-edge drug development strategies.
This is the 13th annual report on global control of tuberculosis (TB) published by WHO. 196 countries and territories that reported data in 2008 account for 99.6% of the world
Feb. 2: Indian scientists have achieved a major breakthrough by developing a single drug that can cure tuberculosis. At present, TB is treated using multi-drug therapy in which each drug targets different metabolic pathways in Mycobacterium, the causative pathogen, trying to cripple it. But the new compound developed jointly by …
This fourth edition of the WHO Guidelines for surveillance of drug resistance in tuberculosis presents up-to-date guidance on the design and implementation of setting-specific surveys and surveillance systems to measure the burden and trends of drug-resistant tuberculosis. The guidelines address recent advancements in drug susceptibility testing, including testing for second-line …
In spite of the dramatic advances made in health care in the past decades, it is hard to believe that tuberculosis (TB) kills three people every two minutes in India. Mycobacterium tuberculosis is one of the oldest infectious agents known to mankind. While infection occurs in 50 per cent of …
Nellore, Nov. 25: In a bid to stop tuberculosis from becoming multi drug resistant, a charitable organisation has been roping in the services of locals to monitor the TB patients in Nellore. The organisation, Damien Foundation India Trust (DFIT) has been entrusting the job of administering the drugs for the …
Cured patients to generate awareness among masses Against a target of detecting 3,984 tuberculosis (TB) patients in the current year, given to Sangrur district in the light of annual risk of TB infection (ARTI) survey (257 patients per lakh per year), as many as 1,680 TB patients, including 591 highly …
Participants in a round table stressed the need for identifying tuberculosis infected people to curb spread of the disease. Many TB patients could not be identified due to ignorance, they said while talking in the meeting titled
MPA Pir Amjad Hussain Jilani has said that people are not getting their children vaccinated against tuberculosis due to unawareness about the disease, and stressed the need for holding seminars, workshops and conventions in the rural areas to make people health-conscious. Speaking at a convention for TB control jointly organised …
A day-long workshop on Anti-Tuberculosis (T.B) for journalists, government officers, social workers was held at Chuadanga Press Club auditorium hall on Tuesday. D.C of Chuadanga Makhlasur Rahman attended the workshop as the chief guest with Azad Molita, President of Chuadanga Press Club in the chair. ASP Rezaul Haque Raza,. Reazul …
Ranked eighth among the highest TB (tuberculosis) burdened countries in the world, Pakistan faces a $100.36 million funding gap for the next five years to fight the lung disease that causes most female deaths as a single infectious agent than all other causes of maternal mortality. Statistics available with Daily …
NEW DELHI Diseases like tuberculosis, malaria and kala azar, which are often considered as diseases of developing countries, will finally get some more contribution and attention from scientists and pharmaceutical companies. Taking a lead to provide a collaborative effort from scientists, doctors, technocrats, students and people with expertise, Union science …
P B Jayakumar / Mumbai September 17, 2008, 1:02 IST Piramal Life Sciences, the demerged research arm of pharmaceutical major Nicholas Piramal India (NPIL), may become the first company to successfully develop a tuberculosis drug whose leads are isolated from the living organisms found in ice brought from the Antarctica …
NEW DELHI: The Council of Scientific and Industrial Research on Monday launched a new initiative to develop low cost drugs for infectious diseases like tuberculosis that afflict mainly the poor in India and other developing countries. Big pharmaceutical companies do not spare much resources for these for want of adequate …
In a path-breaking initiative that has the potential to revolutionalise the drug manufacturing sector, the Council of Scientific and Industrial Research (CSIR) on Monday launched its Open Source Drug Discovery (OSDD) programme with the aim of finding a cheap medicine for tuberculosis. The main objective of the initiative is to …
Research centre plan in crisis Statesman News Service KOLKATA Sept 5: The initiative taken by the Bengal Tuberculosis Association (BTA), a voluntary organisation, to set up a few more research centres along with advanced pathological laboratories for diagnosis of tuberculosis, has run into rough weather owing to paucity of funds …
